XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Total Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non-Controlling Interests
Beginning Balance at Dec. 31, 2020 $ 8,556,073 $ 8,504,825 $ 5,671 $ 9,707,258 $ (661,162) $ (546,942) $ 51,248
Beginning Balance, common stock, shares outstanding (in shares) at Dec. 31, 2020     567,117,666        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Capital distributions (605)           (605)
Net income 57,722 57,367     57,367   355
Dividends and dividend equivalents declared (96,933) (96,933)     (96,933)    
Issuance of common stock — settlement of RSUs, net of tax $ (7,413) (7,413) $ 6 (7,419)      
Issuance of common stock — settlement of RSUs, net of tax (in shares)     532,768        
Issuance of common stock, net (in shares) 532,768            
Share-based compensation expense $ 5,814 5,283   5,283     531
Other comprehensive income 117,702 116,984       116,984 718
Ending Balance at Mar. 31, 2021 8,632,360 8,580,113 $ 5,677 9,705,122 (700,728) (429,958) 52,247
Ending Balance, common stock, shares outstanding (in shares) at Mar. 31, 2021     567,650,434        
Beginning Balance at Dec. 31, 2021 $ 9,838,804 9,797,742 $ 6,010 10,873,539 (794,869) (286,938) 41,062
Beginning Balance, common stock, shares outstanding (in shares) at Dec. 31, 2021 601,045,438   601,045,438        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Capital distributions $ (580)           (580)
Net income 93,003 92,615     92,615   388
Dividends and dividend equivalents declared (134,240) (134,240)     (134,240)    
Issuance of common stock — settlement of RSUs, net of tax (10,972) (10,972) $ 5 (10,977)      
Issuance of common stock — settlement of RSUs, net of tax (in shares)     503,989        
Settled amount of convertible securities 141,219 141,219 $ 62 141,157      
Settled amount of convertible securities (in shares)     6,216,261        
Issuance of common stock, net $ 83,959 83,959 $ 21 83,938      
Issuance of common stock, net (in shares) 8,799,023   2,078,773        
Share-based compensation expense $ 6,646 6,129   6,129     517
Other comprehensive income 207,293 206,404       206,404 889
Ending Balance at Mar. 31, 2022 $ 10,225,132 $ 10,182,856 $ 6,098 $ 11,093,786 $ (836,494) $ (80,534) $ 42,276
Ending Balance, common stock, shares outstanding (in shares) at Mar. 31, 2022 609,844,461   609,844,461